Search
Research
Type 1 DiabetesA lifelong auto-immune condition that can affect anyone, but is most commonly diagnosed in childhood.
News & Events
Navigating the teenage years with type 1 diabetesThe teenage years can be a challenging time for families, a period made even more difficult if a child has type 1 diabetes.
News & Events
30% of children at risk of future heart diseaseAlmost 30% of 14-year-old Australian children fall within a group identified as being at future increased risk of heart disease, type 2 diabetes or stroke
News & Events
High hopes for preventing lowsResearchers led by the team at the Children’s Diabetes Centre at The Kids have taken a key step to a fully automated closed-loop insulin delivery system.
Research
Type 2 Diabetes in Indigenous Australian childrenRates of type 2 diabetes are higher among Indigenous than non-Indigenous Australian children and adolescents.
Research
Type 1 and Type 2 Diabetes DNA bankA register which stores demographic and clinical data on all patients attending the diabetes clinic at Princess Margaret Hospital
Research
Sprint proof of concept studyThis study will evaluate the effect of two types of aerobic exercise
Research
Disparities in Diabetes Technology Uptake in Youth and Young Adults With Type 1 Diabetes: A Global PerspectiveGlobally, nearly 9 million people are living with type 1 diabetes (T1D). Although the incidence of T1D is not affected by socioeconomic status, the development of complications and limited access to modern therapy is overrepresented in vulnerable populations. Diabetes technology, specifically continuous glucose monitoring and automated insulin delivery systems, are considered the gold standard for management of T1D, yet access to these technologies varies widely across countries and regions, and varies widely even within high-income countries.
Research
Real-world glycaemic outcomes in children and young people on advanced hybrid closed-loop therapy: A population-based study in Western AustraliaTo evaluate real-world glycaemic outcomes in children with type 1 diabetes commencing advanced hybrid closed loop therapy and to explore these outcomes based on the cohort's clinical and socioeconomic characteristics.
Research
Priority setting: Development of the South Australian Aboriginal Chronic Disease Consortium RoadMap for ActionAboriginal and Torres Strait Islander (Aboriginal) people in South Australia are overburdened by cardiovascular disease, diabetes and cancer. The South Australian Aboriginal Chronic Disease Consortium (Consortium) was established in June 2017 as a collaborative partnership to lead the implementation of three state-wide chronic disease plans using a strategic approach to identifying key priority areas for action.